NONO and prostate cancer: While neither NonO nor SFPQ has been characterized further in lymphoma/leukemia, the aberrant functions of both have been observed in the etiology of colorectal, hepatocellular, renal, myeloid and prostate cancer ([98]; reviewed in [99]).